Study of Roxadustat Conversion in Subjects Receiving Stable ESA or as Initial Anemia Treatment in Chronic Dialysis Patients

Condition:   Anemia Associated With End Stage Renal Disease (ESRD) Intervention:   Drug: Roxadustat Sponsors:   FibroGen;   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials